The Management Of mCRC Patients Receiving Regorafenib

The Management Of mCRC Patients Receiving Regorafenib

obr

1 year
48 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Howard Hochster, MD, Associate Director for Clinical Research, Rutgers Cancer institute of New jersey, Director of Oncology Research, RWJBarnabas Health discusses, The Management Of mCRC Patients Receiving Regorafenib. At The 2019 Gastrointestinal Cancers Symposium In San Francisco, CA On Jan 17, 2019. http://obroncology.com
Up Next Autoplay